Kayser, S., Benner, A., Müller-Tidow, C., Ho, A. D., Schlenk, R. F., & Krämer, A. (2017). Clinical impact of KMT2C and SPRY4 expression levels in intensively treated younger adult acute myeloid leukemia patients. European journal of haematology, 99(6), . https://doi.org/10.1111/ejh.12972
Chicago-Zitierstil (17. Ausg.)Kayser, Sabine, Axel Benner, Carsten Müller-Tidow, Anthony Dick Ho, Richard Friedrich Schlenk, und Alwin Krämer. "Clinical Impact of KMT2C and SPRY4 Expression Levels in Intensively Treated Younger Adult Acute Myeloid Leukemia Patients." European Journal of Haematology 99, no. 6 (2017). https://doi.org/10.1111/ejh.12972.
MLA-Zitierstil (9. Ausg.)Kayser, Sabine, et al. "Clinical Impact of KMT2C and SPRY4 Expression Levels in Intensively Treated Younger Adult Acute Myeloid Leukemia Patients." European Journal of Haematology, vol. 99, no. 6, 2017, https://doi.org/10.1111/ejh.12972.